Recommended articles

Hormone Replacement Therapy availability varies currently. Check for available products and keep up-to-date. Supply content is maintained regularly by DHSC.
Guidance on strategies for the safe application of transdermal patches to reduce the risk of medication errors in healthcare settings.
Intramuscular hydroxocobalamin is the preferred treatment choice for management of clinically relevant vitamin B12 deficiency, including during pregnancy.
Doxazosin XL tablets should not routinely be prescribed. Guidance is provided on switching doxazosin XL tablets to standard release tablets.
Prescribing medicines by generic name is generally preferred but there are some circumstances when brand-name prescribing is warranted.
National guidance from NHSE/I to reduce LASA errors and improve patient safety when considering requirements for unlicensed specials medicines
Guidance on continuing or initiating commonly used antihistamines whilst breastfeeding. Recommendations apply to full term and healthy infants only.

COVID-19 Vaccines and Treatments

Resources covering pharmaceutical aspects of the vaccination programme specific to COVID-19 Vaccine Pfizer-BioNTech
Resources covering pharmaceutical aspects of the vaccination programme specific to COVID-19 Vaccine Moderna
Oral antivirals may reduce COVID-19 symptoms, progression, transmission, hospitalisation and mortality. We guide on successful deployment for Chief Pharmacists.
Resources covering pharmaceutical aspects of the vaccination programme common to all COVID-19 vaccines
Resources covering pharmaceutical aspects of the vaccination programme specific to COVID-19 Vaccine AstraZeneca
Pharmaceutical processes for Comirnaty (10 micrograms/dose) for Children 5 to 11 years, from initial ordering through to administration for PCNs and Trusts.
Characteristics of Pfizer's Comirnaty vaccines for adults/adolescents and children differ. Teams must understand the differences to ensure safety.
Summary information concerning COVID-19 vaccination in women of child-bearing age or who are pregnant

Recommended in PGDs

National PGD templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.
About PGD exemplar templates The attached PGD templates are based on the version being used to develop the national PGD templates as part of the…

Planning

Latest information on supply issues, actions to take, alternatives to use, and expected resolution dates. Content provided by DHSC and CMU.
Our annual Prescribing Outlook outputs support planning, implementation and budget planning for medicines every year.
Regularly updated new medicines material, in addition to our annual outputs
Regularly updated patent expiry material, in addition to our annual outputs
Regularly updated biosimilars material, in addition to our annual outputs

Recommended for primary care

Summarised recommendations and guidance for medicines requiring monitoring to save you time when you're making monitoring decisions with patients
All our advice on using medicines safely and effectively in patients with swallowing difficulties
All our training and guidance to help decision making about the use of medicines in breastfeeding
All our training and guidance to help decision making about the use of medicines in pregnancy